SARS-CoV-2 rS Nanoparticle Vaccine NVX-CoV2373

Preferred Label : SARS-CoV-2 rS Nanoparticle Vaccine NVX-CoV2373;

NCIt synonyms : SARS-CoV-2 rS Nanoparticle Vaccine;

NCIt related terms : NVX-COV2373;

NCIt definition : A recombinant, nanoparticle-based vaccine consisting of antigen derived from the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) surface antigen spike (S) protein, with potential immunizing activity against SARS-CoV-2. Upon administration, the SARS-CoV-2 rS nanoparticle vaccine NVX-CoV2373 may induce cell-mediated and antibody mediated immune responses against SARS-CoV-2. This may provide active immunization and protection against SARS-CoV-2 infection.;

UNII : UK9AK2IN1P;

Drug name : Nuvaxovid;

Molecule name : NVX-CoV2373; NVX CoV2373;

NCI Metathesaurus CUI : CL1406604;

Details

Origin ID

C172755;

UMLS CUI

C5416844;

CISMeF manual mappings
- NVX-CoV2373 adjuvated lipid nanoparticle [MeSH concept]
Currated CISMeF NLP mapping
- NVX-CoV2373 [COVID-19 Thesaurus concept]
- NVX-CoV2373 adjuvated lipid nanoparticle [MeSH Supplementary Concept]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- NVX-CoV2373 adjuvated lipid nanoparticle [MeSH Supplementary Concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Sensitization [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients